MindWalk Holdings (HYFT) Cash & Equivalents (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Cash & Equivalents came in at $8.3 million in Q2 2026, up 10.46% year-over-year from $7.5 million in Q2 2025, and down 18.36% quarter-over-quarter from $10.1 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Cash & Equivalents (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Cash & Equivalents for 7 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 10.46% year-over-year to $8.3 million in Q2 2026; TTM through Apr 2026 was $8.3 million, a 10.46% increase from a year earlier, with the FY2026 full-year figure at $8.2 million, up 7.42% from the prior year.
- Cash & Equivalents was $8.3 million for Q2 2026 at MindWalk Holdings, down from $10.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $26.1 million in Q1 2022 and troughed at $2.6 million in Q2 2024.
- A 5-year average of $9.1 million and a median of $7.9 million in 2025 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents sank 73.94% in 2023 and soared 348.79% in 2025, its largest moves.
- Over 5 years, Cash & Equivalents stood at $11.3 million in 2022, then tumbled by 60.3% to $4.5 million in 2023, then plunged by 41.1% to $2.7 million in 2024, then jumped by 348.79% to $11.9 million in 2025, then slumped by 30.43% to $8.3 million in 2026.
- The last three Cash & Equivalents figures came in at $8.3 million (Q2 2026), $10.1 million (Q1 2026), and $11.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 1.91 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 192.03 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 928.39 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 404.92 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 84.54 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 8.28 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 1.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 8.28 Mn |
| Jan 31, 2026 | 10.14 Mn |
| Oct 31, 2025 | 11.90 Mn |
| Jul 31, 2025 | 3.56 Mn |
| Apr 30, 2025 | 7.49 Mn |
| Jan 31, 2025 | 9.16 Mn |
| Oct 31, 2024 | 2.65 Mn |
| Jul 31, 2024 | 2.92 Mn |
| Apr 30, 2024 | 2.61 Mn |
| Jan 31, 2024 | 4.65 Mn |
| Oct 31, 2023 | 4.50 Mn |
| Jul 31, 2023 | 5.10 Mn |
| Apr 30, 2023 | 6.18 Mn |
| Jan 31, 2023 | 8.46 Mn |
| Oct 31, 2022 | 11.34 Mn |
| Jul 31, 2022 | 14.96 Mn |
| Apr 30, 2022 | 23.72 Mn |
| Jan 31, 2022 | 26.06 Mn |
| Oct 31, 2021 | 30.51 Mn |
| Jul 31, 2021 | 33.13 Mn |